Abstract 20846: The Impact of a Palliative Care Intervention on Polypharmacy in Advanced HF: Results From Pal-HF
Bradi B. Granger, Joseph G. Rogers(Baylor College of Medicine), Daniel B. Mark(Duke University), C.B. Patel, Robert M. Clare(Duke University), Mona Fiuzat(Duke University), Donald H. Taylor(Duke University), Robert J. Mentz(Duke University), Karen E. Steinhauser(Duke University), Gwen C. Dodson, Hongqiu Yang(University of Maryland, Baltimore), James A. Tulsky(Dana-Farber Cancer Institute), Christopher M. O’Connor(Inova Health System), Kevin Anstrom(PragmatIC (United Kingdom))
Circulation
November 14, 2017
Cited by 0
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k